AMYLYX PHARMACEUTICALS INC (AMLX)
Sector: Health Care
Named Executive Officers
Compensation data for top executives (showing up to 3 years of data)
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Justin Klee Co-Chief Executive Officer and Director | 2025 | $686,200 | $0 | $650,226 | $817,783 | $548,098 | $17,500 | $2,719,807 |
| 2024 | $686,200 | $0 | $2,585,771 | $2,685,179 | $521,855 | $17,250 | $6,496,255 | |
| 2023 | $621,000 | $0 | $1,604,000 | $4,733,928 | $447,741 | $11,500 | $7,418,169 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Joshua Cohen Co-Chief Executive Officer and Director | 2025 | $686,200 | $0 | $650,226 | $817,783 | $548,098 | $17,500 | $2,719,807 |
| 2024 | $686,200 | $0 | $2,585,771 | $2,685,179 | $521,855 | $17,250 | $6,496,255 | |
| 2023 | $621,000 | $0 | $1,604,000 | $4,733,928 | $447,741 | $11,500 | $7,418,169 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Camille L. Bedrosian, M.D. Chief Medical Officer | 2025 | $575,000 | $0 | $246,996 | $312,872 | $275,569 | $157,237 | $1,567,674 |
| 2023 | $56,763 | $173,000 | $754,246 | $1,386,012 | $0 | $2,838 | $2,372,859 |
| Executive | Year | Salary | Bonus | Stock Awards | Option Awards | Non-Equity Incentive Comp | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| James Frates Chief Financial Officer | 2025 | $540,600 | $0 | $246,996 | $311,148 | $259,083 | $17,500 | $1,375,327 |
| 2024 | $540,600 | $0 | $885,672 | $848,404 | $248,427 | $17,250 | $2,540,353 | |
| 2023 | $510,000 | $0 | $695,077 | $2,052,137 | $241,663 | $11,500 | $3,510,377 |